Fairview Capital Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Sell |
326
-80
| -20% | -$62.4K | 0.01% | 146 |
|
|
2025
Q1 | $335K | Sell |
406
-44
| -10% | -$36.3K | 0.02% | 131 |
|
|
2024
Q4 | $347K | Sell |
450
-124
| -22% | -$95.7K | 0.02% | 133 |
|
|
2024
Q3 | $509K | Buy |
574
+221
| +63% | +$196K | 0.03% | 110 |
|
|
2024
Q2 | $320K | Hold |
353
| – | – | 0.02% | 122 |
|
|
2024
Q1 | $275K | Buy |
+353
| New | +$275K | 0.02% | 137 |
|
|
2021
Q3 | – | Sell |
-1,153
| Closed | -$264K | – | 129 |
|
|
2021
Q2 | $264K | Hold |
1,153
| – | – | 0.02% | 112 |
|
|
2021
Q1 | $215K | Buy |
+1,153
| New | +$215K | 0.01% | 150 |
|